<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02068755</url>
  </required_header>
  <id_info>
    <org_study_id>BiCS</org_study_id>
    <nct_id>NCT02068755</nct_id>
  </id_info>
  <brief_title>Blood Products in Cardiac Surgery</brief_title>
  <acronym>BiCS</acronym>
  <official_title>The Use of Blood Products in Patients Undergoing Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Turku</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Finnish Red Cross</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Central Finland Hospital District</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Turku University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oulu University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kuopio University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Satakunta Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Turku</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Blood transfusion is a common procedure essential for the treatment of patients undergoing
      cardiac surgery. Inappropriate transfusions, however, not only incur needless healthcare
      costs, but increase unnecessary risks due to transfusion reactions and infectious and
      immunomodulative causes. Safe and appropriate patient care requires evaluated blood component
      prescription practices.

      Practically all patients undergoing cardiac surgery in Finland have a blood product booking
      from the Finnish Red Cross Blood Service. This registry contains large volumes of
      transfusion-related information on all Finnish patients undergoing cardiac surgery in Finnish
      centers. Participating hospitals were scattered to all geographical areas in Finland and
      concentrated to the most populated regions.

      Data on the blood product use, laboratory findings one month pre-operatively and 12 months
      post-operatively were available.

      Finnish hospitals have been required to provide information on hospital visits for the
      Finnish National Research and Development Centre for Welfare and Health for healthcare
      planning purposes. We used in part the original data sent by hospitals to the Finnish
      Hospital Discharge Register (FHDR).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Registry includes

        -  &gt;21 000 patients who underwent coronary bypass,

        -  &gt;4500 patients with aortic valve replacement,

        -  &gt;4000 mitral valve operation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2002</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Red blood cell infusions</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Platelet infusion</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Fresh frozen plasma</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Octaplas</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>myocardial infarction</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TIA/stroke/arterial embolism</measure>
    <time_frame>12</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>re-operation due to bleeding</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">31000</enrollment>
  <condition>Anemia</condition>
  <condition>Renal Impairment</condition>
  <condition>Thrombocytopenia</condition>
  <arm_group>
    <arm_group_label>Cardiac surgery</arm_group_label>
    <description>Patients who have undergone cardiac surgery</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        We collected data from patients who visited underwent cardiac surgery in Finnish hospitals
        during the years 2002 and 2012. Participating perform all the cardiac surgery in Finland
        and hospitals were scattered to all geographical areas in Finland.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cardiac surgery performed in Finnish University and Central hospitals

          -  Blood product booking for surgery

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pirjo Mustonen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Central Finland Central Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Juhani Airaksinen, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Turku University Hospital and University of Turku</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fausto Biancari, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oulu University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tuomas O Kiviniemi, Md, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Turku University Hospital and University of Turku</affiliation>
  </overall_official>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2014</study_first_submitted>
  <study_first_submitted_qc>February 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 21, 2014</study_first_posted>
  <last_update_submitted>February 19, 2014</last_update_submitted>
  <last_update_submitted_qc>February 19, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 21, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Turku</investigator_affiliation>
    <investigator_full_name>Dr. Pirjo Mustonen, MD, PhD</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>anemia</keyword>
  <keyword>renal impairment</keyword>
  <keyword>thrombocytopenia</keyword>
  <keyword>anticoagulation</keyword>
  <keyword>Coronary bypass</keyword>
  <keyword>Aortic valve surgery</keyword>
  <keyword>Mitral valve surgery</keyword>
  <keyword>red blood cell</keyword>
  <keyword>platelet</keyword>
  <keyword>fresh frozen plasma</keyword>
  <keyword>octaplas</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombocytopenia</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

